相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?
E. V. McCloskey et al.
OSTEOPOROSIS INTERNATIONAL (2022)
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club
Michael R. Laurent et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Management of patients at very high risk of osteoporotic fractures through sequential treatments
Elizabeth M. Curtis et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)
Dairy products and bone health
Rene Rizzoli
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)
Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies
Christos Chalitsios et al.
THORAX (2021)
Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures
Alexander Egeberg et al.
JAMA DERMATOLOGY (2021)
Practical Guidance for Prevention and Management of Glucocorticoid-Induced Osteoporosis for the Allergist/Immunologist
Natalia Weare-Regales et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020)
Rosa M. R. Pereira et al.
ARCHIVES OF OSTEOPOROSIS (2021)
Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
Yasuaki Hirooka et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines A report for the National Osteoporosis Guideline Group (NOGG)
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2021)
Management of glucocorticoid-induced osteoporosis
Osvaldo D. Messina et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)
Vitamin D supplementation: upper limit for safety revisited?
Rene Rizzoli
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2020)
MRI Assessment of Bone Marrow Composition in Osteoporosis
Xiaojuan Li et al.
CURRENT OSTEOPOROSIS REPORTS (2020)
High fracture risk patients with glucocorticoid-induced osteoporosis should get an anabolic treatment first
E. Lespessailles et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Short-Term Glucocorticoid Treatment Reduces Circulating Sclerostin Concentrations in Healthy Young Men: A Randomized, Placebo-Controlled, Double-Blind Study
Merel Jacobsson et al.
JBMR PLUS (2020)
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures
Francesco Ferrau et al.
ENDOCRINE (2020)
A decade of FRAX: how has it changed the management of osteoporosis?
John A. Kanis et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2020)
Glucocorticoid-induced osteoporosis: 2019 concise clinical review
G. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics
Christopher R. Shuhart et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
FRAX-based intervention and assessment thresholds in seven Latin American countries
P. Clark et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture
Anne V. Gonzalez et al.
CHEST (2018)
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
Kenneth G. Saag et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Anabolic Therapy for the Treatment of Osteoporosis in Childhood
Leanne M. Ward et al.
CURRENT OSTEOPOROSIS REPORTS (2018)
Osteoporosis Therapy With Denosumab in Organ Transplant Recipients
Jana Brunova et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
New FRAX-based intervention and assessment thresholds for the Ecuadorian population
Enrique Lopez Gavilanez et al.
ARCHIVES OF OSTEOPOROSIS (2018)
The Effectiveness of Combined Exercise Interventions for Preventing Postmenopausal Bone Loss: A Systematic Review and Meta-analysis
Renqing Zhao et al.
JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS CARE & RESEARCH (2017)
UK clinical guideline for the prevention and treatment of osteoporosis
J. Compston et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
C. M. Weaver et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Association between alcohol consumption and Korean young women's bone health: a cross sectional study from the 2008 to 2011 Korea National Health and Nutrition Examination Survey
Seonwha Seo et al.
BMJ OPEN (2015)
Effectiveness of two year balance training programme on prevention of fall induced injuries in at risk women aged 75-85 living in community: Ossebo randomised controlled trial
Fabienne El-Khoury et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Effectiveness of two year balance training programme on prevention of fall induced injuries in at risk women aged 75-85 living in community: Ossebo randomised controlled trial
Fabienne El-Khoury et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Glucocorticoid-induced osteoporosis: who to treat with what agent?
Rene Rizzoli et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Effects of maternal bisphosphonate use on fetal and neonatal outcomes
Sarah B. Green et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2014)
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis
Karine Briot et al.
JOINT BONE SPINE (2014)
Bone Health in Children and Adolescents With Chronic Diseases That May Affect the Skeleton: The 2013 ISCD Pediatric Official Positions
Maria Luisa Bianchi et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions
Nick Bishop et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
N. Duru et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study
Jeffrey M. Muir et al.
BMC MUSCULOSKELETAL DISORDERS (2013)
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial
Claus-C Glueer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
S. Lekamwasam et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The use of bisphosphonates in women prior to or during pregnancy and lactation
Stathopoulos P. Ioannis et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2011)
Interpretation and use of FRAX in clinical practice
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review
Rym Boulkedid et al.
PLOS ONE (2011)
Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
Alan L. Burshell et al.
BONE (2010)
Fracture risk assessment in Latin America: is Frax (TM) an adaptable instrument for the region?
Jorge Morales-Torres et al.
CLINICAL RHEUMATOLOGY (2010)
Pregnancy outcome following in utero exposure to bisphosphonates
Shirley Levy et al.
BONE (2009)
Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
S. Aubrey Stoch et al.
JOURNAL OF RHEUMATOLOGY (2009)
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
David M. Reid et al.
LANCET (2009)
The role of physical activity in the prevention of osteoporosis in postmenopausal women-An update
Natalie M. Schmitt et al.
MATURITAS (2009)
A Comparison of Calcium, Calcitriol, and Alendronate in Corticosteroid-Treated Premenopausal Patients with Systemic Lupus Erythematosus
Swan S. Yeap et al.
JOURNAL OF RHEUMATOLOGY (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Balance training program is highly effective in improving functional status and reducing the risk of falls in elderly women with osteoporosis: a randomized controlled trial
M. M. Madureira et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men
Laura M. Cruse et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2006)
Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: A report of four cases
Brendan Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis
H Kaji et al.
ENDOCRINE JOURNAL (2006)
Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate
F Richy et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise - Results of a randomized, controlled trial
Z de Jong et al.
ARTHRITIS AND RHEUMATISM (2004)
Loss of bone density with inhaled triamcinolone in Lung Health Study II
PD Scanlon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Effects of physical activity and dietary calcium intake on bone mineral density and osteoporosis risk in a rural Thai population
C Pongchaiyakul et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases
CFJ Munns et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy
TP Van Staa et al.
ARTHRITIS AND RHEUMATISM (2003)
The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis
TP van Staa et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Use of oral corticosteroids and risk of fractures
TP Van Staa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
分享论文
